INCY logo

Incyte (INCY)

Profile

Full Name

Incyte Corporation

Ticker Symbol

INCY

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

November 4, 1993

Indexes

S&P 500

Website

http://www.incyte.com

Employees

2617

Key Details

Price

$58.46(-1.28%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$4.24B(+14.76% YoY)

Annual EPS

$0.15(-94.34% YoY)

PE ratio

216.52

Next earnings date

Apr 29, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$58.46
INCY price is $58.46

30-Day Relative Volume

0.66
INCY 30-day relative volume is 0.66

Price Performance

Price Today change

-1.28%
INCY price is down -1.28% today

Price YTD change

-15.36%
INCY price is down -15.36% since January 1st

Price 1-year change

+9.41%
INCY price is up +9.41% year-on-year

Price 3-year change

-28.48%
INCY price is down -28.48% over the past 3 years

Price Range

Price All-time high

$153.15
INCY price is currently -61.83% below its historical high of $153.15

Price 3-year low

$50.27
INCY price is currently +16.29% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$11.31B
INCY market capitalization is $11.31 billion

Market cap 3-year change

-37.49%
INCY market capitalization is down -37.49% over the past 3 years

Market cap All-time high

$31.12B
INCY market capitalization is currently -63.64% below its historical high of $31.12 billion

Market cap sector rank

93.26%
INCY market capitalization is higher than 93.26% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-13.81%
INCY shares outstanding is down -13.81% year-on-year

Shares Outstanding 3-Year Change

-12.59%
INCY shares outstanding is down -12.59% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.48
INCY beta is 0.48

200-day SMA

$67.69
INCY price is currently -13.64% below its 200-day simple moving average

50-day SMA

$66.30
INCY price is currently -11.82% below its 50-day simple moving average

RSI

40.63
INCY 14-day relative strength index is 40.63

Volume

0.66
INCY 30-day relative volume is 0.66

ATR

$2.69
INCY average true range is $2.69

10-day Historical Volatility

58.55%
INCY 10-day historical volatility is 58.55%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$4.24B
INCY annual revenue is $4.24 billion

Revenue Analysts estimate

$4.66B
INCY annual revenue is currently -9.04% lower than the consensus analysts' forecast

Revenue 1-year change

+14.76%
INCY annual revenue is up +14.76% year-on-year

Revenue Sector rank

91.04%
INCY annual revenue is higher than 91.04% of companies in Healthcare sector

EPS

EPS

$0.15
INCY annual earnings per share is $0.15

EPS Analysts estimate

$5.82
INCY annual earnings per share is currently -97.42% lower than the consensus analysts' forecast

EPS 1-year change

-94.34%
INCY annual earnings per share is down -94.34% year-on-year

EPS Sector rank

84.37%
INCY annual earnings per share is higher than 84.37% of companies in Healthcare sector

Profit

Gross profit

$3.93B
INCY annual gross profit is $3.93 billion

Gross margin

92.64%
INCY annual gross profit margin is 92.64%

Operating profit

$101.29M
INCY annual operating income is $101.29 million

Operating margin

2.39%
INCY annual operating profit margin is 2.39%

Net income

$32.62M
INCY annual net profit is $32.62 million

Net margin

0.77%
INCY annual net profit margin is 0.77%

Expenses

Total expenses

$4.14B
INCY annual total expenses is $4.14 billion

Operating expenses

$3.83B
INCY annual total operating expenses is $3.83 billion

Cost of goods sold

$312.10M
INCY annual cost of goods sold is $312.10 million

Selling, general & administrative expenses

$1.22B
INCY annual SGA is $1.22 billion

Depreciation and amortization

$89.25M
INCY annual depreciation & amortization is $89.25 million

Interest expense

$2.28M
INCY annual interest expense is $2.28 million

Income tax

$284.01M
INCY annual income tax is $284.01 million

EBIT & EBITDA

EBIT

$318.91M
INCY annual earnings before interest & taxes is $318.91 million

EBITDA

$408.16M
INCY annual EBITDA is $408.16 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$5.44B
INCY annual total assets is $5.44 billion

Non current assets

$2.21B
INCY annual long term assets is $2.21 billion

Current assets

$3.24B
INCY annual total current assets is $3.24 billion

Cash and cash equivalents

$1.69B
INCY annual cash & cash equivalents is $1.69 billion

Accounts receivable

$853.15M
INCY annual accounts receivable is $853.15 million

Inventory

$58.87M
INCY annual inventory is $58.87 million

Liabilities

Total liabilities

$2.00B
INCY annual total liabilities is $2.00 billion

Long term liabilities

$354.85M
INCY annual total long term liabilities is $354.85 million

Current liabilities

$1.64B
INCY annual total current liabilities is $1.64 billion

Accounts payable

$197.47M
INCY annual accounts payable is $197.47 million

Debt

Total debt

$43.54M
INCY annual total debt is $43.54 million

Total debt 1-year change

+13.73%
INCY annual total debt is up +13.73% year-on-year

Long term debt

$33.54M
INCY annual long term debt is $33.54 million

Short term debt

$10.00M
INCY annual short term debt is $10.00 million

Equity & Capital

Shareholders equity

$3.45B
INCY annual stockholders equity is $3.45 billion

Book value

$3.45B
INCY annual book value is $3.45 billion

Retained earnings

-$1.07B
INCY annual retained earnings is -$1.07 billion

Working capital

$1.60B
INCY annual working capital is $1.60 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$335.34M
INCY annual cash flow from operations is $335.34 million

Cash from operations 1-year change

-32.46%
INCY annual cash flow from operations is down -32.46% year-on-year

Cash from investing

$157.52M
INCY annual cash flow from investing activities is $157.52 million

Cash from investing 1-year change

+175.85%
INCY annual cash flow from investing activities is up +175.85% year-on-year

Cash from financing

-$2.02B
INCY annual cash flow from financing activities is -$2.02 billion

Cash from financing 1-year change

-9991.08%
INCY annual cash flow from financing activities is down -9991.08% year-on-year

CAPEX

CAPEX

$100.16M
INCY annual capital expenditures is $100.16 million

CAPEX 1-year change

+110.93%
INCY annual capital expenditures is up +110.93% year-on-year

Free Cash Flow

Free cash flow

$235.17M
INCY annual free cash flow is $235.17 million

Free cash flow 1-year change

-47.62%
INCY annual free cash flow is down -47.62% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

92.64%
INCY annual gross profit margin is 92.64%

Operating margin

2.39%
INCY annual operating profit margin is 2.39%

Net margin

0.77%
INCY annual net profit margin is 0.77%

ROA & ROE

ROA

0.53%
INCY annual return on assets is 0.53%

ROE

0.76%
INCY annual return on equity is 0.76%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

216.52
INCY price to earnings ratio is 216.52

PE ratio Sector rank

95.1%
INCY price to earnings ratio is higher than 95.1% of companies in Healthcare sector

PB Ratio

PB ratio

3.28
INCY price to book ratio is 3.28

PB ratio Sector rank

74.16%
INCY price to book ratio is higher than 74.16% of companies in Healthcare sector

PS Ratio

PS ratio

2.67
INCY price to sales ratio is 2.67

PS ratio Sector rank

49.36%
INCY price to sales ratio is higher than 49.36% of companies in Healthcare sector

Enterprise value

Enterprise value

$9.67B
INCY enterprise value is $9.67 billion

Enterprise value Sector rank

91.74%
INCY enterprise value is higher than 91.74% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

23.69
INCY EV/EBITDA is 23.69

EV/EBITDA Sector rank

93.13%
INCY EV/EBITDA is higher than 93.13% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.97
INCY annual current ratio is 1.97

Quick ratio

1.94
INCY annual quick ratio is 1.94

Leverage

Debt to equity

0.00
INCY annual debt to equity ratio is 0.00

Interest coverage ratio

139.87
INCY annual interest coverage ratio is 139.87

Risk & Stability

Piotroski F-Score

6
INCY piotroski f-score is 6

Altman Z-Score

4.45
INCY altman z-score is 4.45

Analyst ratings

Recent major analysts updates

Mar 24, 25 Morgan Stanley
Equal-Weight
Mar 18, 25 William Blair
Market Perform
Mar 18, 25 Truist Securities
Hold
Mar 18, 25 Guggenheim
Neutral
Mar 11, 25 Citizens Capital Markets
Market Perform
Feb 11, 25 RBC Capital
Sector Perform
Feb 11, 25 JMP Securities
Market Perform
Feb 11, 25 Citigroup
Buy
Feb 10, 25 Stifel
Hold
Jan 23, 25 RBC Capital
Sector Perform

Institutional Ownership

Similar stocks

SNN logo
Smith & Nephew (SNN)
SOLV logo
Solventum (SOLV)
UHS logo
Universal Health Services (UHS)
BMRN logo
BioMarin Pharmaceutical (BMRN)
RVTY logo
Revvity (RVTY)
THC logo
Tenet Healthcare (THC)
RDY logo
Dr Reddys Laboratories Limited (RDY)
DVA logo
DaVita (DVA)
ICLR logo
ICON Public Limited (ICLR)
  • What is the ticker symbol for Incyte?
  • Does Incyte pay dividends?
  • What sector is Incyte in?
  • What industry is Incyte in?
  • What country is Incyte based in?
  • When did Incyte go public?
  • Is Incyte in the S&P 500?
  • Is Incyte in the NASDAQ 100?
  • Is Incyte in the Dow Jones?
  • When was Incyte's last earnings report?
  • When does Incyte report earnings?
  • Should I buy Incyte stock now?

What is the ticker symbol for Incyte?

The ticker symbol for Incyte is NASDAQ:INCY

Does Incyte pay dividends?

No, Incyte does not pay dividends

What sector is Incyte in?

Incyte is in the Healthcare sector

What industry is Incyte in?

Incyte is in the Biotechnology industry

What country is Incyte based in?

Incyte is headquartered in United States

When did Incyte go public?

Incyte's initial public offering (IPO) was on November 4, 1993

Is Incyte in the S&P 500?

Yes, Incyte is included in the S&P 500 index

Is Incyte in the NASDAQ 100?

No, Incyte is not included in the NASDAQ 100 index

Is Incyte in the Dow Jones?

No, Incyte is not included in the Dow Jones index

When was Incyte's last earnings report?

Incyte's most recent earnings report was on Feb 10, 2025

When does Incyte report earnings?

The next expected earnings date for Incyte is Apr 29, 2025

Should I buy Incyte stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page